[The microbiological monitoring as a basis of epidemiological control and anti-microbial therapy in conditions of multi-type hospital.].

The study was carried out to investigate features of microbiota and resistance to antibiotics of agents isolated from bio-material of patients in the conditions of multi-type hospital. The microbiological analysis was applied to 6148 samples using optimal set of corresponding techniques (classical tests, chromogenic mediums, immune serological, Maldi-Tof mass spectrometry). The resistance to antibiotics was established by using disk diffusion test (EUCAST 2016, Adagio analyzer).

[THE INFECTION INDUCED BY STREPTOCOCCUS OF SEROGROUP B IN PREGNANT WOMEN, PUERPERA AND NEWBORNS].

The streptococci of serogroup B (Streptococcus agalactiae) are one of major etiologic agents responsible for occurrence of severe perinatal infections in puerpera and newborns. The prevalence of streptococci of group B is analyzed in various categories of women (stage of preconception training, pregnancy, puerpera) and newborns transferred for particular reasons to second stage of raising. The data of microbiological monitoring during four years was involved.

[The role of Paenibacillus polymyxa lectin in the macrophages-mediated killing of bacteria].

Influence of lectin LII of Paenibacillus polymyxa 1460, specific for galactosamine, glucuronic acid, fructose-1,6-diphosphate, and glucosamine, on mechanisms of oxygen-dependent and oxygen-independent killing of bacteria was reviewed. It was shown that the lectin modulates the activity of some microbicide factors in the cytoplasm of macrophages before phagocytosis. Increased activity of myeloperoxidase and acid phosphatase, enhanced formation of active forms of oxygen in alveolar macrophages, increased level of cationic proteins and decreased activity of alkaline phosphatase in peritoneal macrophages was observed.

[Clinical and vascular effects of ACE inhibitor enalapril in combination with thiaside-like diuretic indapamide in hypertensive outpatients. Results of the multicenter trial POEMA].

Aim: To evaluate efficacy and safety of a 6-month treatment of 237 patients with arterial hypertension (AH) of degree 1-3 with ACE inhibitor enalapril (mean dose 21.9 +/- 9.0 mg/day), 49.